- | Recovery | - | Major Adverse Cardiac Events | |
---|---|---|---|---|
- | OR (95% CI) | P value | OR (95% CI) | P value |
Age | 1.12 (1.02-1.23) | 0.021 | 1.10 (1.00-1.21) | 0.057 |
Black race | 0.27 (0.06-1.15) | 0.075 | 0.18 (0.04-0.70) | 0.014 |
Baseline EF | 1.06 (1.01-1.12) | 0.021 | 1.05 (0.99-1.11) | 0.080 |
Beta-blocker | 2.13 (0.32-14.01) | 0.431 | 1.38 (0.21-9.14) | 0.740 |
ACE-Inhibitor | 0.87 (0.13-5.69) | 0.882 | 1.38 (0.21-9.14) | 0.740 |
Spironolactone | 3.19 (0.93-10.92) | 0.064 | 0.56 (0.15-2.12) | 0.396 |
Loop Diuretic | 0.16 (0.02-1.56) | 0.114 | 0.47 (0.05-4.55) | 0.514 |
Digoxin | 0.18 (0.05-0.6) | 0.005 | 0.15 (0.04-0.62) | 0.009 |
Hypertension | 1.09 (0.34-3.46) | 0.889 | 1.00 (0.30-3.38) | 1.000 |
Diabetes Mellitus | 0.5 (0.11-2.19) | 0.360 | 0.70 (0.17-2.90) | 0.619 |
Pre-eclampsia | 2.92 (0.73-11.65) | 0.130 | 1.44 (0.33-6.29) | 0.631 |